教職

國防醫學院醫學系放射腫瘤學科臨床實習指導教師 2016年8月~迄今

經歷

三軍總醫院放射腫瘤部住院醫師 2016年8月～2019年7月
三軍總醫院放射腫瘤部總住院醫師 2019年8月～2020年7月
三軍總醫院放射腫瘤部資深住院醫師 2020年8月～2021年2月
三軍總醫院放射腫瘤部主治醫師 2021年2月～迄今

專長學科

放射腫瘤學、輻射生物學、放射物理學
肺癌、乳癌、肝癌、胃癌、直腸癌、攝護腺癌等腫瘤放射治療
影像導引放射治療
立體定位放射治療

專業證照

放射腫瘤科專科醫師

論文發表

1. Shen PC, Chang WC, Lo CH, Yang JF, Lee MS, Dai YH, Lin CS, Fan CY, Huang WY. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):307-318. doi: 10.1016/j.ijrobp.2019.05.066. Epub 2019 Jun 5. PMID: 31175903.

2. Shen PC, Lo CH, Lin KZ, Tsao CC, Yang JF, Liu MY, Chao HL, Huang WY, Chen CM, Lin CS. Outcomes of Stereotactic Ablative Radiotherapy in the Treatment of Sarcoma Pulmonary Metastases: Case Reports. Therapeut Radiol Oncol 2018;6(0), p151-159. doi: 10.6316/TRO.201806_25(2)0009

3. Wang YF, Dai YH, Lin CS, Chang HC, Shen PC, Yang JF, Hsiang CW, Lo CH, Huang WY. Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series. Radiat Oncol. 2021 Jan 14;16(1):15. doi: 10.1186/s13014-020-01739-5.

4. Lo CH, Lee HL, Hsiang CW, Chiou JF, Lee MS, Chen SW, Shen PC, Lin CS, Chang WC, Yang JF, Dai YH, Chen CY, Chia-Hsien Cheng J, Huang WY. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):474-484. doi: 10.1016/j.ijrobp.2020.09.001.

5. Huang WY, Tsai CL, Que JY, Lo CH, Lin YJ, Dai YH, Yang JF, Shen PC, Lee MH, Cheng JC. Development and Validation of a Nomogram for Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy. Liver Cancer. 2020 Jun;9(3):326-337. doi: 10.1159/000505693

6. Yang JF, Lo CH, Lee MS, Lin CS, Dai YH, Shen PC, Chao HL, Huang WY. Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis. Radiat Oncol. 2019 Oct 22;14(1):180. doi: 10.1186/s13014-019-1382-1.

7. Lin CS, Chen YW, Liu SC, Tsao CC, Lin KT, Lee SP, Fan CY, Liu MY, Shen PC, Jen YM. Treatment outcomes with whole-field versus split-field intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Head Neck. 2019 Mar;41(3):598-605. doi: 10.1002/hed.25328. Epub 2018 Dec 31. PMID: 30597692.